FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:122-124 January 8, 1998 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Iacoviello, L. PubMed Citation

By the time the Beagle left the waters of the remote Galapagos Islands, Charles Darwin had still not realized that the natural variations within a species would provide the means for its evolution. Later, the Galapagos finches furnished ideal support for his theory of natural selection, because after a long separation from the finches of the rest of the world, they had become highly inbred. Geographic isolation had restricted their gene pool, so that the subtle differences Darwin saw among the island finches must have resulted from genetic changes, or polymorphisms, that arose spontaneously in individual birds and were then . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Tanabe, K. K., Lemoine, A., Finkelstein, D. M., Kawasaki, H., Fujii, T., Chung, R. T., Lauwers, G. Y., Kulu, Y., Muzikansky, A., Kuruppu, D., Lanuti, M., Goodwin, J. M., Azoulay, D., Fuchs, B. C. (2008). Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis. JAMA 299: 53-60 [Abstract] [Full Text]  
• Holmes, C. L., Russell, J. A., Walley, K. R. (2003). Genetic Polymorphisms in Sepsis and Septic Shock: Role in Prognosis and Potential for Therapy. Chest 124: 1103-1115 [Abstract] [Full Text]  
• Swynghedauw, B. (2002). Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes. Eur Heart J 23: 271-273 [Full Text]  
• Agema, W. R. P., Jukema, J. W., Pimstone, S. N., Kastelein, J. J. P. (2001). Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy. Eur Heart J 22: 2058-2074  
• Gerdes, L. U., Gerdes, C., Kervinen, K., Savolainen, M., Klausen, I. C., Hansen, P. S., Kesaniemi, Y. A., Fargeman, O. (2000). The Apolipoprotein {epsilon}4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction : A Substudy of the Scandinavian Simvastatin Survival Study. Circulation 101: 1366-1371 [Abstract] [Full Text]  
• JUKEMA, J W. (1999). Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease. Heart 82: 126-127 [Full Text]  
• Kastrati, A., Schomig, A., Seyfarth, M., Koch, W., Elezi, S., Bottiger, C., Mehilli, J., Schomig, K., von Beckerath, N. (1999). PlA Polymorphism of Platelet Glycoprotein IIIa and Risk of Restenosis After Coronary Stent Placement. Circulation 99: 1005-1010 [Abstract] [Full Text]  
• Altshuler, D., Kruglyak, L., Lander, E. (1998). Genetic Polymorphisms and Disease. NEJM 338: 1626-1626 [Full Text]